Record transaction volumes and significant North American capital inflows have, over the past year, cemented the UK as Europe’s preferred destination for healthcare real estate investment.
Structural demand growth — driven by demographic ageing and rising acuity — combined with persistent supply constraints, has established the sector as a consistent...
Authors Dr Lakshiv Dhingra, Dr Seren Marsh, Abhishek Patel and Dr Victor Chua of Mansfield Advisors consider how the GLP-1 landscape will evolve over the next 10 years in light of: increasing competition and the entry of generics; how reimbursement dynamics will shape penetration in the US and the EU5 (France, Germany, Italy, Spain and the UK); and emerging treatment paradigms that may reshape demand in what is already a US$70bn-plus global market.
The success of GLP-1 weight loss drugs has reshaped the pharmaceutical landscape and created one of the...
